PlumeStars is pleased to inform you that Professor Ruggero Bettini, member of the company, has been elected to the American Institute for Medical and Biological Engineering (AIMBE) College of Fellows.
AIMBE is a non-profit, honorific society of the most accomplished individuals in the fileds of medical and biological engineering. AIMBE’s missions is to advocate for biomedical engineering innovation through public policy initiatives.
No other organization brings together academia, industry, government, and scientific societies into a highly influential community in medical and biological engineering.
Being part of the AIMBE College of Fellows enables intimate networking and public policy engagement among trailblazers at the pinnacle of their careers.
on behalf of the PlumeStars’s Team wish you a wonderful holiday season and a happy new year!
PlumeStars actively participated at the DDL 2018 , Drug delivery to the Lungs conference held on 12, 13 and 14 December at Edinburgh.
The Drug Delivery to the Lungs conference (DDL) is Europe’s premier conference and industry exhibition which is dedicated to pulmonary and nasal drug delivery.
Read more “PlumeStars attended at the DDL 2018”
PlumeStars actively participated at the 58th AFI Symposium, the Italian Conference of the Industrial Pharmacists, held on 6, 7 and 8 June at the Pala Congressi in Rimini. The symposium has registered more than 1000 attendees and more than 100 stands, reconfirming itself as a meeting point for excellence which revolves around the pharmaceutical world.
Read more “PlumeStars attended the 58th AFI Symposium”
In occasion of the Annual Conference of the European Association of Pharmacy 2018: 16-18 May, Parma, Italy, the Food and Drug Department of the University of Parma, in collaboration with the Innovative SME PlumeStars, announces the organization of the Pre-Conference Workshop Medicines for rare diseases, Wednesday, May 16th, 2018, Aula Magna, Via Università 12, Parma, Italy.
Read more “May 16th 2018: Pre-Conference Workshop “Medicines for rare diseases”, in collaboration with University of Parma”
PlumeStars attended the 2017 AAPS Annual Meeting & Exposition in San Diego presenting a poster on the last orphan medicine getting the EMA and FDA orphan designation. The orphan medicine presented was the powder of thalidomide prepared for both the oral and nasal administration.
Read more “12-15 November: AAPS Annual Meeting and Exposition in San Diego”